130
Participants
Start Date
November 10, 2021
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Adalimumab plus different doses of oral glucocorticosteroid
A loading dose of 80mg adalimumab will be given subcutaneously and then change to 40mg adalimumab every two weeks. Medium dose oral glucocorticosteroid (30mg/d prednisone or equivalent) will be given to the experimental dose group and high dose oral glucocorticosteroid (60mg/d prednisone or equivalent) will be given to the high dose group.
Peking Union Medical College Hospital
OTHER